Antonio Finelli

Dr. Antonio Finelli

Chief of Urology, Professor at the University of Toronto, and Anna-Liisa Farquharson Chair in Kidney Cancer Research, University Health Network, Toronto


Dr. Antonio Finelli is the Chief of Urology, within the Department of Surgical Oncology at Princess Margaret Cancer Centre. A urologic oncologist, clinician investigator and an Professor at the University of Toronto, Dr. Finelli also holds the post of inaugural Ontario Genitourinary Cancer Lead for CCO. He is also the Head of Genitourinary Cancer Site Group at Princess Margaret Cancer Centre and Anna-Liisa Farquharson Chair in Kidney Cancer Research.

Tony Finelli attended the University of Toronto where he earned his Doctor of Medicine. Later he completed his postgraduate training in urology and a Master’s of Science degree through the Surgical Scientist Program. Dr. Finelli received advanced training in minimally invasive urologic oncology at the Cleveland Clinic Foundation and undertook another Master’s degree in the department of Health, Policy, Management and Evaluation. He was also the recipient of the Bernard Langer Surgeon Scientist Award that acknowledges an outstanding graduate of the Surgeon Scientist Program in the Department, who shows the greatest promise for a career in academic surgery.

Dr. Finelli’s clinical practice focuses on the management of urologic malignancies and in particular prostate and kidney cancer. His expertise and research interests span from clinical trials to retrospective research including natural history, active surveillance, treatment and quality of health care delivery. In 2015 Dr. Finelli was recognized as one of Toronto’s top 30 doctors.

He has received peer-reviewed funding for his research and has produced more than 185 manuscripts. He has also received several major scientist awards and grants from agencies such as CIHR, PCC and CCSRI both as the principal investigator ad co-investigator. Dr. Finelli is recognized nationally and internationally for his contributions to minimally invasive and robotic urologic surgery. Through his pioneering work, almost 40 percent of the hospital’s prostatectomies are done robotically compared to only 4 percent when Dr. Finelli started at UHN. He has been the driving force behind the efforts of getting the Ministry of Health to support robot assisted surgery in Ontario .

Funded Projects

Dissecting Papillary Renal Cell Carcinoma on the Molecular Level: Subtype Analysis, Biomarker Discovery and Implications to Therapy »

Research Specialties

Research Interests

  • Urological

Contact for Collaboration

University Health Network
Pathologists and Researchers who are interested in being part of the OMPRN: